Analystreport

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its price target raised by analysts at Chardan Capital from $56.00 to $60.00. They now have a "buy" rating on the st

Rocket Pharmaceuticals, Inc.  (RCKT) 
Last rocket pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rocketpharma.com